Literature DB >> 30239869

Population description and clinical response assessment for spinal metastases: the SPINO group report.

Jared Fridley1, Ziya Gokaslan1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30239869      PMCID： PMC6071647          DOI： 10.1093/neuonc/noy107

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  4 in total

1.  A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis.

Authors:  Yasuaki Tokuhashi; Hiromi Matsuzaki; Hiroshi Oda; Masashi Oshima; Junnosuke Ryu
Journal:  Spine (Phila Pa 1976)       Date:  2005-10-01       Impact factor: 3.468

2.  Surgical strategy for spinal metastases.

Authors:  K Tomita; N Kawahara; T Kobayashi; A Yoshida; H Murakami; T Akamaru
Journal:  Spine (Phila Pa 1976)       Date:  2001-02-01       Impact factor: 3.468

3.  Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.

Authors:  Martin Reck; Delvys Rodríguez-Abreu; Andrew G Robinson; Rina Hui; Tibor Csőszi; Andrea Fülöp; Maya Gottfried; Nir Peled; Ali Tafreshi; Sinead Cuffe; Mary O'Brien; Suman Rao; Katsuyuki Hotta; Melanie A Leiby; Gregory M Lubiniecki; Yue Shentu; Reshma Rangwala; Julie R Brahmer
Journal:  N Engl J Med       Date:  2016-10-08       Impact factor: 91.245

4.  Psychometric evaluation and adaptation of the Spine Oncology Study Group Outcomes Questionnaire to evaluate health-related quality of life in patients with spinal metastases.

Authors:  Anne L Versteeg; Arjun Sahgal; Laurence D Rhines; Daniel M Sciubba; James M Schuster; Michael H Weber; Peter Pal Varga; Stefano Boriani; Chetan Bettegowda; Michael G Fehlings; Michelle J Clarke; Paul M Arnold; Ziya L Gokaslan; Charles G Fisher
Journal:  Cancer       Date:  2018-02-06       Impact factor: 6.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.